✦ LIBER ✦

P.3.c.040 Risk of metabolic, cardiologic, and endocrinologic abnormalities in patients under long-term antipsychotic treatment

✍ Scribed by G. Cerveri; P. Ala; L. Volonteri; I. Netti; C. Mencacci

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P.3.c.031 Risk of metabolic, cardiologic

✍ G. Cerveri; A. Mazzocchi; L.S. Volonteri; C. Mannussakis; C. Mencacci 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 58 KB

P.3.c.032 Gender differences and risk of

✍ G. Cerveri; A. Mazzocchi; L.S. Volonteri; I. Netti; C. Mencacci 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 193 KB

P.3.c.027 Metabolic syndrome, cardiovasc

✍ J. Castaño; B. Diaz; C. Garnier; R. Sanchis; A. Horta; A. Navarro; R. Navines; L 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 57 KB

P.3.c.040 Effect of lurasidone on weight

✍ A. Pikalov; J. Cucchiaro; M. Ogasa; R. Silva; J. Hsu; J. Xu; A. Loebel 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 74 KB

P.3.c.037 Antipsychotic polypharmacy in

✍ J. Chang; D. Roh; S.K. Ann; H.S. Cho; Y.C. Jung; B.H. Oh; C.H. Kim 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 61 KB

P.3.c.019 Risk of pathological decrease

✍ R. Marin; R. Lozano; M.D. Vazquez; M.J. Santacruz; F. Sebastian; A. Pascual; A. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 76 KB